These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
99 related articles for article (PubMed ID: 172307)
21. Studies of the Epstein-Barr herpesvirus relationship with Hodgkin's disease and the use of virus immunological markers in differential diagnostics of nasopharyngeal carcinoma. Mazurenko NP; Gurtsevich VE; Stepina VN; Plakhov IV Arch Geschwulstforsch; 1983; 53(3):253-9. PubMed ID: 6311138 [No Abstract] [Full Text] [Related]
22. The value of cytologic examination for nasopharyngeal carcinoma. Chan MK; Huang DP Ear Nose Throat J; 1990 Apr; 69(4):268-71. PubMed ID: 2161733 [TBL] [Abstract][Full Text] [Related]
23. The Epstein-Barr Virus (EBV) in Burkitt's lymphoma and nasopharyngeal carcinoma. Henle W; Henle G Ann Clin Lab Sci; 1974; 4(2):109-14. PubMed ID: 4362218 [No Abstract] [Full Text] [Related]
24. Localization of Epstein-Barr virus in lymph node metastasis with nasopharyngeal carcinoma. Akao I; Sato Y; Mukai K; Sugano S; Hoshikawa T; Suzuki T; Tsutsumi K Acta Otolaryngol Suppl; 1996; 522():86-8. PubMed ID: 8740817 [TBL] [Abstract][Full Text] [Related]
25. [Undifferentiated carcinoma of the nasopharynx associated with the Epstein-Barr virus. Diagnostic value of EBV serology]. Souillet G; Maisonneuve J; Lenoir G; Gilly J; Brunat-Mentigny M; Duc H; Hermier M Pediatrie; 1980 Sep; 35(6):541-4. PubMed ID: 6255403 [No Abstract] [Full Text] [Related]
26. Antibody response against the Epstein-Barr virus-coded nuclear antigen2 (EBNA2) in nasopharyngeal carcinoma. Chatani M; Teshima T; Inoue T; Yoshino K; Ikegami N; Hirai K; Shimakage M Laryngoscope; 1991 Jun; 101(6 Pt 1):626-9. PubMed ID: 1645832 [TBL] [Abstract][Full Text] [Related]
27. A prospective evaluation of patients with nasopharyngeal carcinoma: an overview. Neel HB J Otolaryngol; 1986 Jun; 15(3):137-44. PubMed ID: 3014165 [TBL] [Abstract][Full Text] [Related]
29. [Demonstration of Epstein-Barr virus genome in european Burkitt lymphoma (author's transl)]. Wutzler P; Sprössig M; Hirsch J; Brichaćek B; Vonka V; Schindler E; Wutke K; Rüdiger KD; Wöckel W Dtsch Med Wochenschr; 1980 Jul; 105(27):961-6. PubMed ID: 6250783 [TBL] [Abstract][Full Text] [Related]
30. Detection of Epstein-Barr virus DNA in formalin-fixed paraffin-embedded tissue of nasopharyngeal carcinoma using polymerase chain reaction and in situ hybridization. Akao I; Sato Y; Mukai K; Uhara H; Furuya S; Hoshikawa T; Shimosato Y; Takeyama I Laryngoscope; 1991 Mar; 101(3):279-83. PubMed ID: 1847985 [TBL] [Abstract][Full Text] [Related]
31. Serological and immunohistological assessment of Epstein-Barr virus infection in Sicilian patients with suspected nasopharyngeal carcinoma. Ammatuna P; de Thè G; Speciale R; Sammartano F; Arista S; Zerillo G Microbiologica; 1988 Apr; 11(2):89-94. PubMed ID: 2841559 [TBL] [Abstract][Full Text] [Related]
32. Epstein-Barr virus-related lymphocyte stimulation inhibitor: a possible prognostic tool for undifferentiated nasopharyngeal carcinoma. Kamaraju LS; Levine PH; Sundar SK; Ablashi DV; Faggioni A; Armstrong GR; Bertram G; Krueger GR J Natl Cancer Inst; 1983 Apr; 70(4):643-7. PubMed ID: 6300502 [TBL] [Abstract][Full Text] [Related]
33. [Detection of EB virus-specific IgA antibody from patients with nasopharyngeal carcinoma by immunoenzymic method (author's transl)]. Liu YX; Zeng Y; Dong WP; Cao GR Zhonghua Zhong Liu Za Zhi; 1979; 1(1):8-12. PubMed ID: 233233 [No Abstract] [Full Text] [Related]
34. [Relationship between natural cytotoxicity activity, Epstein-Barr virus (EBV) antibody titer and clinical status in nasopharyngeal carcinoma patients]. Mu M Zhonghua Er Bi Yan Hou Ke Za Zhi; 1988; 23(1):46-9. PubMed ID: 2856431 [No Abstract] [Full Text] [Related]
35. [Detection of Epstein-Barr virus DNA in fine needle aspiration specimen from cervical lymphnodes with polymerase chain reaction]. Lei ZX; Liu QR; Yuan P Lin Chuang Er Bi Yan Hou Ke Za Zhi; 2000 Oct; 14(10):454-5. PubMed ID: 12563716 [TBL] [Abstract][Full Text] [Related]
36. [A rare nasopharyngeal tumor: Hodgkin's disease]. Strutz J; Zöllner C; Wannenmacher M; Mann W Laryngol Rhinol Otol (Stuttg); 1988 Jan; 67(1):38-40. PubMed ID: 3347135 [TBL] [Abstract][Full Text] [Related]
37. Nasopharyngeal carcinoma: the diagnostic value of the antibody-dependent, cellular cytotoxicity test and of EBV serology. Faggioni A; Corradini C; Venanzoni M; Cardi G; Bevere F; Barile G; Zompetta C; Frati L J Exp Pathol; 1987; 3(4):471-7. PubMed ID: 2842480 [TBL] [Abstract][Full Text] [Related]
38. [Value of Epstein-Barr virus serology during radiotherapy of undifferentiated carcinoma of the nasopharynx]. Yomi J; Fouda A; Fossi A; Bejanga B Bull Cancer Radiother; 1996; 83(3):168-9. PubMed ID: 8977568 [No Abstract] [Full Text] [Related]
39. Epstein-Barr virus is not associated with head and neck neoplasms other than nasopharyngeal carcinoma. Kottaridis SD; Goula I; Kiparissiadis P Neoplasma; 1982; 29(3):327-31. PubMed ID: 6290911 [No Abstract] [Full Text] [Related]
40. [A specific histological marker of undifferentiated carcinoma of the nasopharynx. The ACIF (Anti-Complement Immunofluorescence) test]. Micheau C; De The G; Schwaab G; Tursz T; Sancho-Garnier H; Montagu B Ann Pathol; 1984; 4(2):143-6. PubMed ID: 6329239 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]